Company intelligence
Ozgene
to advance humanity - inspire curiosity
About Ozgene
Ozgene is a global contract research organisation delivering end to end genetically engineered mouse model solutions for academic, biotechnology, and pharmaceutical researchers worldwide. From custom model design and generation to breeding, genotyping, phenotyping, colony management, and vivarium operations, we provide integrated services that accelerate scientific discovery and drug development. Our proprietary goGermline™ technology enables fast, reliable model generation with enhanced 3Rs compliance, while our OzBIG platform supports large genomic insertions and complex humanised mouse models. With more than 25 years of experience and operations spanning Australia, the United States, and the Cayman Islands, Ozgene combines advanced model generation technologies with commercial breeding, embedded vivarium services, digital research infrastructure, and operational consulting to deliver flexible, scalable solutions. We operate AAALAC accredited facilities in the United States and Australia, offer in sourced breeding and facility management services globally, and are the authorised distributor of JAX strains in Australia, New Zealand, and Indonesia, providing local access to high quality stock mice and rats. Our global centres of expertise include: 🇦🇺 Perth, Australia: Custom humanized, knockout and knock in mouse model generation, stock mouse and rat lines, breeding, validation, and preclinical research services. 🇺🇸 Indianapolis, USA: Custom breeding, genotyping, and vivarium services for academic, biotech, and pharmaceutical clients. 🇺🇸 Boston/Cambridge, USA: Embedded preclinical vivarium care, digitised workflows, and integration with client systems. 🇰🇾 George Town, Cayman Islands: Global consulting, operating model design, vivarium design and certification, digital systems, operational workflows, and infrastructure support. 🇩🇪 Munich, Germany: Scientific research project consulting, regional office.
Verified activity
Signals from Ozgene
2 published signals